The long term objective of this proposal is the development of cryopreservation methods which cause less interstitial tissue damage than methods currently employed for preservation of heart valves. The underlying hypothesis is that rapid deterioration observed in some patients is due to interstitial ice damage which occurs during cryopreservation and subsequently leads to calcification upon implantation. The Phase I aims are screening two synthetic antifreeze compounds designed by the company in combination with naturally occurring antifreeze peptides, an antifreeze glycoprotein and selected cryoprotectants. First ice formation will be studied and antifreeze/cryoprotectant formulations will be selected based on ice morphology during freezing and thawing. Second, the selected formulations will be tested in vitro for cytotoxicity and cell survival during controlled rate freezing. Lastly, ice formation in porcine heart valves will be studied using minimally toxic formulations which promote cell viability during freezing. The formulations that provide the highest cell viability and least ice formation will be later tested in larger animal allograft models.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43HL059731-01
Application #
2537495
Study Section
Special Emphasis Panel (ZRG7-SSS-W (06))
Project Start
1998-01-15
Project End
2002-05-31
Budget Start
1998-01-15
Budget End
2002-05-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Life Resuscitation Technologies, Inc.
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60614
Brockbank, Kelvin G M; Song, Ying C (2003) Mechanisms of bioprosthetic heart valve calcification. Transplantation 75:1133-5
Brockbank, K G; Lightfoot, F G; Song, Y C et al. (2000) Interstitial ice formation in cryopreserved homografts: a possible cause of tissue deterioration and calcification in vivo. J Heart Valve Dis 9:200-6